Fig. 1.

Cochran–Mantel–Haenszel relative risks of treatment-emergent adverse events (TEAEs) in System Organ Class (SOC) categories (a) and of specific preferred terms (b) after postoperative treatment with HPβCD-diclofenac compared with placebo. Presented SOC categories and preferred terms are those identified as having a significantly different incidence across the three age groups (see Table 3). Data for some SOC categories or preferred terms are missing due to a lack of incidence in the placebo group preventing the calculation of relative risk